ADVERTISEMENT
LIVE DESK·Global markets desk·Last updated 14s ago
ADVERTISEMENT
Markets/EquitiesArticle

Wolverine Q2 2026 results beat estimates, outlook raised

Footwear maker Wolverine reported second-quarter 2026 earnings that exceeded expectations, prompting an upward revision to full-year guidance.

PA
Priya Anand · Equities & Earnings Desk · 16 Aug 2026 · 1 min read
Share
Wolverine Q2 2026 results beat estimates, outlook raised

Wolverine World Wide Inc. reported second-quarter 2026 adjusted earnings per share of $0.85, topping the $0.78 consensus estimate compiled by Refinitiv. Revenue rose 8% year-over-year to $312 million, also surpassing the $305 million forecast.

The company attributed the outperformance to strong demand for its Merrell and Wolverine brands, particularly in North America and international markets. Gross margin expanded to 48.2%, up from 46.5% in the same period last year, driven by pricing power and operational efficiencies.

Based on the quarterly results, Wolverine raised its full-year 2026 adjusted EPS guidance to a range of $3.10 to $3.20, up from the prior range of $2.90 to $3.10. The company also increased its revenue outlook to $1.25 billion to $1.27 billion, from $1.20 billion to $1.24 billion previously.

Wolverine maintained its focus on direct-to-consumer growth and digital expansion, noting a 15% increase in e-commerce sales during the quarter. Inventory levels were reduced by 5% compared to the prior year, reflecting improved supply chain management.

The raised guidance reflects confidence in sustained consumer demand and disciplined cost controls, the company said. Shares were indicated higher in pre-market trading following the results.

This article was produced with AI assistance and edited by a Finance Review Daily journalist.
ADVERTISEMENT
Novara — A Smarter Way to Access Global Markets
Share this story
PA
Written by
Priya Anand
Equities & Earnings Desk

Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.

More from Priya Anand →
ADVERTISEMENT
ADVERTISEMENT